Skip to main navigation Skip to search Skip to main content

Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts

  • Juan José Vilata
  • , Xavier Badia
  • , M. V. Aguanell
  • , F. Albero
  • , A. Albert
  • , J. Alonso
  • , C. Alsina
  • , M. T. Arguisjuela
  • , Asín
  • , J. Balaguer
  • , J. Ballesteros
  • , N. Bañuls
  • , Ali Bassem
  • , B. Bilbao
  • , J. Borbujo
  • , J. Boronat
  • , D. Bou
  • , M. Camara
  • , M. Cararach
  • , B. Carrillo
  • A. Casasús, A. Castells, A. Castizo, M. Castro, P. Cavallé, C. Centeno, J. A. Colombo, C. Colomo, J. R. Curto, J. M. Del Solar, P. De Unamuno, Diez, M. Durán, J. Egea, M. Fariña, J. M. Fernández Vozmediano, E. Fonseca, M. Formigón, I. Frias, P. Fusté, M. García Font, A. García Iglesias, J. M. García Marqués, M. García Rodríguez, J. M. Garzón Sánchez, J. Gayete Martínez, E. Gimeno, A. González Martín, E. González Mirasol, C. Grau, P. Hergueta, F. Hernández Torres, P. Herranz, S. Jamal, J. Jo Chu, E. Jorda, N. Landa, R. Llamas, Ll Llistosella, I. Lepe, A. López Salvá, A. Marquina, E. Martínez Jordá, J. Miralles, A. Miranda, S. Moreno, J. I. Moriñigos, J. Muñoz, J. Mut, J. Navas, V. Navarro, I. Nieto, B. Numancia, M. Nwelati, A. Ojeda, L. Olmos, F. Ortiz, Pagerols, F. Palomeque, M. Perea, N. Perulero, I. Pueyo, L. M. Puig, M. Quílez, M. J. Reyes, Rementeria, L. Ríos, C. Rodríguez Cerdeira, J. R. Rodríguez García, M. Rodríguez Prieto, M. Roset, D. Rubio, M. Saben, N. Salvatella, M. Sainz De Los Terreros, B. Sanz, M. Sánchez Hernández, J. L. Sánchez Porro, M. T. Sarán

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

This study aims to evaluate the effectiveness of imiquimod treatment of external anogenital warts and analyse its possible relationship with patient treatment satisfaction and compliance under conditions of routine clinical practice. An observational, prospective and multi-centre study was conducted in a cohort of 559 patients with external anogenital warts. Imiquimod 5% cream was administered three times a week until the end of treatment (complete wart clearance or up to a maximum of 16 weeks). Effectiveness and compliance were evaluated at four weeks and again at the end of treatment, when satisfaction was also assessed. Complete wart clearance was experienced by 66.6% of patients at the end of treatment and a 50% or greater reduction in total wart area occurred in 79.5%. Imiquimod was more effective in patients who were more satisfied and compliant with treatment. Under conditions of routine clinical practice, imiquimod is an effective treatment for external anogenital warts.

Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalInternational Journal of STD and AIDS
Volume14
Issue number1
DOIs
StatePublished - 01 Jan 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Compliance
  • Effectiveness
  • External anogenital warts
  • Imiquimod
  • Satisfaction

Fingerprint

Dive into the research topics of 'Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts'. Together they form a unique fingerprint.

Cite this